Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.061 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |